Cerity Partners LLC Buys Shares of 4,994 Amedisys, Inc. (NASDAQ:AMED)

Key Points

• Cerity Partners LLC acquired 4,994 shares of Amedisys, Inc. in the first quarter, valued at approximately $463,000.
• Amedisys reported a quarterly earnings per share (EPS) of $1.25, exceeding analysts' expectations of $1.13, with a revenue of $594.78 million.
• 94.36% of Amedisys stock is owned by institutional investors, highlighting significant interest from hedge funds and investment firms.

Cerity Partners LLC acquired a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,994 shares of the health services provider's stock, valued at approximately $463,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC raised its stake in Amedisys by 108.1% during the 1st quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock valued at $29,000 after acquiring an additional 161 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in Amedisys by 56.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after acquiring an additional 120 shares during the last quarter. Fifth Third Bancorp raised its stake in Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after acquiring an additional 141 shares during the last quarter. UMB Bank n.a. raised its stake in Amedisys by 100.0% during the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock valued at $36,000 after acquiring an additional 193 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new stake in Amedisys during the 4th quarter valued at approximately $55,000. 94.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AMED has been the subject of a number of analyst reports. Royal Bank Of Canada reissued an "outperform" rating and set a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th. Wall Street Zen downgraded Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th.

Amedisys Price Performance

Shares of AMED traded up $0.11 on Friday, reaching $97.94. The stock had a trading volume of 417,520 shares, compared to its average volume of 400,474. The firm has a market capitalization of $3.21 billion, a PE ratio of 36.14, a PEG ratio of 1.33 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average of $96.34 and a 200 day moving average of $93.97. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.12. The business had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. Amedisys had a return on equity of 12.52% and a net margin of 3.79%. The company's revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 EPS. Sell-side analysts expect that Amedisys, Inc. will post 4.4 EPS for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.